September not kind to investors

Historically, this is the month that the three main averages of the stock market usually perform the poorest. It doesn’t have to happen, but my advice would be to tread carefully in September.

The “September Effect” is a market anomaly worldwide. It is unrelated to any event or news. The Dow Jones Industrial Average as well as the S&P 500 Index have averaged a decline of 0.8% and 0.5% respectively since 1950 during this month. In the period from 1928 through 2021, the benchmark S&P had an even worse record, down 1% on average.

The only reasonable explanation might be that investors tend to cash in on gains made throughout the sleepy summer, but that’s just a guess. As for the historical track record, I pay attention, although I need more reasons than seasonality to make me wary.

In any event, stocks regained quite a bit of the August 5.5% sell-off by the end of the month. I was expecting a bounce and I got it. Quarterly corporate earnings helped somewhat. On average, earnings came in better than expected.

Volume has been extremely light throughout the month since most of the financial community was on vacation. Only skeleton staff manned the trading desks and that allowed traders to push the averages higher on fewer and fewer stocks.

The economic data this week also helped support the markets. Remember that bad economic news is good for the stock market right now. The weaker the data the higher the chance that the Fed will pause or even cease raising interest rates.

The second quarter Gross Domestic Product was revised downward by 0.3% to 2.1%.

The Fed’s key inflation indicator, the Personal Consumer Expenditure Index (PCE) came in as expected with a gain of 0.2%, which was no change versus last month.

On the jobs front, both the Jobs Openings and Labor Turnover Survey (JOLTS) and ADP National Employment Report data indicated that new job creation slowed substantially last month. Both data points are considered a leading indicator of the labor market. A recent non-farm payroll revealed that the economy only added 187,000 new jobs and the unemployment rate rose to 3.8%. Bad news for labor but good news for the Fed which wanted to see employment gains slow.

On another subject, the marijuana industry had a good week. Many pot stocks saw gains of between 30-50%. Several marijuana exchange-traded funds also spiked higher. Why?

The Health and Human Services, after reviewing the present status of marijuana in the U.S. at the behest of the Biden Administration, recommended to the Drug Enforcement Agency (DEA) that the classification of marijuana be changed from a Schedule 1 controlled substance to a Schedule III drug. What’s the difference?

A Schedule I drug is considered one “with no currently accepted use and a high potential for abuse.” A Schedule III substance has “moderate to low potential for physical and psychological dependence.” If the DEA were to re-classify marijuana, it would then be considered a drug like ketamine, anabolic steroids, and testosterone, which are all Schedule III drugs. The difference in schedules could provide a large boost in sales, cash flow, and profits for American-based pot purveyors. My advice is to hold back if you have an itch to play this sector.

All the stocks are up a huge amount and will likely be subject to profit-taking shortly.

The week before Labor Day weekend is usually up. Check that one off the list. The risk going forward during the next few weeks is that we pull back to re-test the lows made on the S&P 500 Index in mid-August. From a technical point of view, that would be perfectly normal. But, if we break that level (roughly 4,432 or -5.5% from here), then we could go even lower,

How much lower? A rough guess would be down to the 4,200 level give or take. 

 

Bill Schmick is a founding partner of Onota Partners Inc. in the Berkshires. None of his commentary is or should be considered investment advice.  Email him at bill@-schmicksretiredinvestor.com.

The views expressed here are not necessarily those of The Lakeville Journal and The Journal does not support or oppose candidates for public office.

Latest News

Wake Robin public hearing closes

Aradev LLC’s plans to redevelop Wake Robin Inn include four 2,000-square-foot cabins, an event space, a sit-down restaurant and fast-casual counter, a spa, library, lounge, gym and seasonal pool. If approved, guest room numbers would increase from 38 to 57.

Provided

LAKEVILLE — The public hearing for the redevelopment of Wake Robin Inn is over. Salisbury Planning and Zoning Commission now has two months to make a decision.

The hearing closed on Tuesday, Sept. 9, after its seventh session.

Keep ReadingShow less
Celebrating diverse abilities at Stanton Home fundraiser

The Weavery is Stanton Home’s oldest activity space, featuring a collection of vintage and modern floor looms. It offers opportunities for building dexterity, creative expression, and social connection through fiber arts.

Provided

Stanton Home is holding its annual Harvest Roast fundraiser on Saturday, Sept. 13 in Great Barrington, an evening of farm-to-table dining, live swing music, and community connection.

For nearly 40 years, Stanton Home has supported adults with intellectual and developmental disabilities through residential programs, therapeutic services and skill-building activities.

Keep ReadingShow less
Sharon Playhouse presents staged reading of ‘Die Mommie Die!’
Charles Busch wrote and stars in ‘Die Mommie Die!’ at Sharon Playhouse.
Provided

Following the memorable benefit reading last season of Charles Busch’s Tony-nominated Broadway hit, “The Tale of the Allergist’s Wife,” the Sharon Playhouse will present a one-night-only staged reading of his riotous comic melodrama “Die Mommie Die!” on Friday, Sept. 12 at 7 p.m.

The production —a deliciously over-the-top homage to classic Hollywood mid-century thrillers — ­­continues the Playhouse’s artistic partnership with Busch, who reprises his iconic role of the glamorous yet troubled songstress Angela Arden.

Keep ReadingShow less